Effect of a single injection of lincomycin, spectinomycin, and linco-spectin on early chick mortality caused by Escherichia coli and Staphylococcus aureus.
The efficacies of lincomycin (L) and spectinomycin (S), alone and in various combinations (L/S), were determined against Escherichia coli (EC) and Staphylococcus aureus (SA) of avian origin, both in vitro and in vivo. L contributed significantly to L/S activity against SA, while S contributed significantly to L/S activity against EC, and L/S (2.5 mg L + 5.0 mg S) was more effective than either L or S against SA and EC. The suggested optimum dose for controlling early chick mortality caused by SA and EC is 2.5/5.0 mg of L/S per chick.
D000818:Animals; D002645:Chickens; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004927:Escherichia coli Infections / Q000188:drug therapy*; D008034:Lincomycin / Q000627:therapeutic use*; D008297:Male; D011201:Poultry Diseases / Q000188:drug therapy*; D000198:Spectinomycin / Q000627:therapeutic use*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus
D000198:Spectinomycin; D008034:Lincomycin